Abstract
Background:
Fear of progression (FoP) is a prevalent psychological issue among stroke patients. Previous studies failing to distinguish characteristics of patient groups with varying FoP levels. Latent profile analysis (LPA) classifies individuals into distinct subgroups via continuous FoP indicators, boosting classification accuracy by accounting for variable uncertainty. Given FoP’s heterogeneity, investigating FoP profiles and their influencing factors in stroke patients is clinically significant for personalized psychological care and improved patient quality of life.
Methods:
A total of 366 stroke patients were selected as study subjects through convenience sampling, and a cross-sectional survey was conducted. FoP was assessed using the Fear of Progression Questionnaire-Short Form (FoP-Q-SF, 2 dimensions, 12 items). Independent variables included demographic characteristics, clinical indicators, the Recurrence Risk Perception Scale for Stroke patients (RRPSS), and the Medical Coping Modes Questionnaire (MCMQ). LPA was performed on the FoP-Q-SF items to identify subgroups. The R3STEP method was used to analyze influencing factors of subgroup membership, and the BCH method was applied to compare differences in distal outcomes across subgroups. Statistical significance was set at p < 0.05.
Results:
The study sample had a mean age of 63.93 ± 10.58 years, with 70.5% males and 65.0% first-ever stroke patients. Two latent profiles were identified: Low-FoP Adaptive Type (C1, 48.6%) and High-FoP Sustained Type (C2, 51.4%). The R3STEP showed that age 18–59 years (OR = 0.476, 95%CI = 0.245–0.924, p = 0.028), hypertension comorbidity (OR = 0.402, 95%CI = 0.237–0.683, p = 0.001), higher RRPSS score (OR = 0.971, 95%CI = 0.946–0.995, p = 0.022), MCMQ-confrontation (OR = 0.920, 95%CI = 0.863–0.982, p = 0.011), and MCMQ-avoidance (OR = 0.796, 95%CI = 0.723–0.876, p < 0.001) were significant influencing factors (all p < 0.05). BCH analysis indicated that C2 patients had higher RRPSS score (p < 0.001), higher NIHSS score (p = 0.002) and lower adaptive coping ability than C1.
Conclusion:
This study revealed significant heterogeneity in FoP among stroke patients. Age, hypertension comorbidity, excessive recurrence risk perception, MCMQ-confrontation, and MCMQ-avoidance were associated with high FoP. Healthcare providers should prioritize identifying high-risk individuals and develop tailored interventions to reduce FoP and improve rehabilitation outcomes.
1 Introduction
Globally, stroke ranks as the second leading cause of mortality (11.6% of total deaths) and the third leading cause of disability (5.7% of total disability-adjusted life-years; Feigin et al., 2021). It is also the primary cause of mortality and disability in adults in China (Ma et al., 2021). Studies have shown recurrence risks of 3.54 to 24.50% within the first year following an index stroke (Pu et al., 2018). This rises to 9.40 to 22.90% over 5 years (Kumral et al., 2015). Approximately 80% of survivors experience varying degrees of functional impairment (Stinear et al., 2020), and over 33% of patients develop depression (Liu et al., 2023). The significant incidence and disability rates of stroke severely impact patients’ well-being and generate substantial burdens for families and society. During rehabilitation, patients often face ongoing concerns about disease recurrence, functional decline, and loss of social roles, leading to a pervasive psychological fear known as “Fear of Progression (FoP)” (Ferro and Santos, 2020).
FoP refers to an individual’s fear of potential disease recurrence, deterioration, or progression, encompassing concerns about the physiological, psychological, and social consequences of disease development, as well as a general fear of threats to life and health (Zhang et al., 2023). Among stroke patients, over 50% fear stroke recurrence (Choi and Lee, 2017), particularly the potential for death or severe disability. Transient, moderate fear can motivate positive health behaviors (Lebel et al., 2013), but persistent or excessive FoP may impair physical-functional recovery, mental health, and coping strategies (Reb et al., 2020). This can delay rehabilitation, increase the risk of recurrence, and ultimately adversely affect disease prognosis, quality of life, and medical resource utilization (Lebel et al., 2013). Notably, an Asian study explained, stroke-related disability is closely associated with psychological distress, which inadvertently exacerbates FoP (Weerasekara et al., 2024). This highlights the urgency of addressing psycho-social aspects in stroke rehabilitation.
Latent profile analysis (LPA) is a person-centered analysis that focuses on the heterogeneity of individual responses by classifying individuals into distinct subgroups with common profiles (Marsh et al., 2009). However, existing research on FoP has predominantly focused on patients with cancer and cardiac disorders (Schapira et al., 2022; Wang X. et al., 2024), while studies on FoP in patients with stroke remain scarce. Furthermore, previous studies often treated patients as a homogeneous group, using scale scores to reflect fear levels. This study implements LPA to stratify FoP subgroups among stroke survivors and elucidate the contributing determinants, thereby generating evidence-based guidelines for precision clinical interventions.
2 Method
2.1 Participants
This study enrolled 366 patients with stroke from three tertiary care hospitals in Gansu Province, China. The 300–500 participant range was derived from LPA-based sample size calculation protocols (Ferguson et al., 2020). The inclusion criteria for participants were as follows: (a) age ≥ 18 years, (b) confirmed by computed tomography or magnetic resonance imaging, (c) participants were conscious and capable of completing the questionnaire independently, (d) all participants provided voluntary written informed consent. The exclusion criteria were as follows: (a) patients with severe comorbidities affecting major organ systems (e.g., cardiac, pulmonary, or renal), (b) patients currently enrolled in other clinical studies.
2.2 Measures
The demographic questionnaire covered age, gender, occupation, marital status, residence area, education, and monthly income.
The National Institutes of Health Stroke Scale (NIHSS) is clinically employed to assess neurological deficits and track progression in stroke patients (Runde, 2020). Scores range from 0 to 45, with higher values indicating more severe impairment. Stroke was classified as mild (0–4), moderate (5–15), or severe (> 15).
The Fear of Progression Questionnaire-Short Form (FoP-Q-SF) evaluates the fear of disease progression (Mahendran et al., 2020). The Chinese version of this scale, which was sinicized and revised by Wu et al. (2015), comprises two dimensions (physical health and social-family) and includes 12 items. Responses are measured on a 5-point Likert scale (1 = never, 5 = always). Total scores range from 12 to 60, with higher scores reflecting a greater FoP. A cutoff score of ≥ 34 indicates clinically significant psychological dysfunction. The Cronbach’s α coefficient for the total scale is 0.883, while the coefficients for the physical health and social-family dimensions are 0.829 and 0.812, respectively. This scale demonstrates robust reliability and validity and has been extensively utilized in China.
The Recurrence Risk Perception Scale for Patients with Stroke (RRPSS) was developed by Lin et al. (2021a) (Chinese version, Cronbach’s α = 0.850). It includes two sections: Section 1 evaluates subjective recurrence likelihood, and Section 2 (17 items, 3 dimensions) assesses recurrence-related concerns. Scores range from 18 to 76, with higher values indicating greater perceived recurrence risk.
The Medical Coping Modes Questionnaire (MCMQ) measures coping styles in stroke patients (Shen and Jiang, 2000). This 20-item version covers three dimensions: confrontation, avoidance, and resignation (4-point Likert scale). In this study, Cronbach’s α coefficients were 0.64 (confrontation), 0.85 (avoidance), and 0.67 (resignation). Widely applied in clinical research to evaluate patients’ coping strategies, this scale still boasts extensive application value in coping style assessment despite the fact that some dimensional coefficients failed to reach the ideal standard.
2.3 Procedures
Our study was approved by the Ethics Committee of Lanzhou University Second Hospital (Approval No. 2025A-658), administrative clearance was obtained from the three participating hospitals prior to data collection, and written informed consent was obtained from all patients. A pretest was conducted in 20 stroke patients to evaluate the clarity and feasibility of the questionnaires. Based on pretest feedback, two ambiguous items in the RRPSS were revised (e.g., “I worry about recurrence” was clarified to “I often worry about stroke recurrence in daily life”). Investigators (3 nursing graduate students) received standardized training on questionnaire administration, including verbal administration skills, confidentiality principles, and on-site verification procedures, with a training pass rate of 100%. For individuals with limited literacy (education level ≤ primary school) or elderly participants (age ≥75 years), items were verbally administered item-by-item by trained investigators. On-site verification was conducted immediately after questionnaire completion to ensure no missing or contradictory responses. All participant responses were de-identified to ensure confidentiality.
2.4 Data analysis
We analyzed participants’ demographic characteristics using descriptive statistics. LPA was conducted using Mplus 8.3 software with the following technical parameters: (1) Estimator: Robust maximum likelihood (MLR); (2) Convergence criteria: Maximum iterations = 10,000; (3) Random starts: 500 initial stage starts, 100 final stage starts; (4) Optimization: Multiple group optimization; (5) Local maxima check: Solutions from 10 independent random start sets were compared to ensure the global maximum likelihood solution was obtained. Manifest indicators were the 12 items of the FoP-Q-SF. Model fit was evaluated using Akaike Information Criterion (AIC), Bayesian Information Criterion (BIC), Adjusted Bayesian Information Criterion (ABIC), Entropy, Lo–Mendell–Rubin (LMR) test, and Bootstrap Likelihood Ratio Test (BLRT). The optimal class number was determined by: (a) lower AIC/BIC/ABIC; (b) Entropy > 0.80; (c) significant LMR/BLRT (p < 0.05) indicated a superior fit of the K class model over the K-1 class model (Tein et al., 2013).
After identifying latent profiles: (1) Univariate analyzes: Chi-square tests and ANOVA were used to compare differences between subgroups; (2) Influencing factors: R3STEP method was used to assess the association between independent variables and subgroup membership (reference group: C1); (3) Distal outcome comparison: BCH method was applied to compare differences in NIHSS, RRPSS, and MCMQ scores across subgroups (controlling for classification error).
Statistical significance was set at p < 0.05. LPA was conducted in Mplus 8.3, and other analyzes were performed using SPSS 27.0.
3 Results
3.1 Demographic and clinical characteristics
Our study initially surveyed 370 stroke patients, after excluding 4 invalid questionnaires, the final analyzed sample comprised 366 cases, yielding a valid response rate of 99%. The mean age of the sample was 63.93 ± 10.58 years. This study included 258 males (70.5%), 148 workers/farmers (40.4%), 44 patients (12.0%) living alone, and 126 patients (34.4%) with primary school education or below.
Disease-related clinical data of the patients: 238 patients (65.0%) experienced first-ever strokes, 179 patients (48.9%) had multiple lesions, 257 (70.2%) were comorbid with hypertension, 125 (34.3%) with diabetes mellitus, and 60 (16.4%) with cardiovascular diseases. Functional assessments revealed that 67 patients (17.9%) had moderate-to-severe dependence on self-care abilities, and 91 (24.9%) were classified as having moderate-to-severe strokes based on NIHSS scores. The mean scale scores were as follows: FoP-Q-SF (32.67 ± 11.84), RRPSS (51.62 ± 10.43), and MCMQ (38.84 ± 5.96). The results are shown in Table 1.
Table 1
| Variables | Class 1 n(%) | Class 2 n(%) | χ2 /F | p |
|---|---|---|---|---|
| Age(years) | ||||
| 18–59 | 47(26.4) | 71(37.8) | 5.402a | 0.020* |
| ≥60 | 131(73.6) | 117(62.2) | ||
| Gender | ||||
| Male | 138(77.5) | 120(63.8) | 8.648a | 0.004* |
| Female | 40(22.5) | 68(36.2) | ||
| Occupation | ||||
| Employed | 15(8.4) | 20(10.6) | 7.675a | 0.104 |
| Retired | 77(43.3) | 57(30.3) | ||
| Unemployed | 9(5.1) | 15(8) | ||
| Worker/Farmer | 64(36.0) | 84(44.7) | ||
| Freelancer | 13(7.3) | 12(6.4) | ||
| Marital status | ||||
| Single | 3(1.7) | 4(2.1) | 1.469a | 0.689 |
| Married | 165(92.7) | 170(90.4) | ||
| Divorced | 2(1.1) | 1(0.5) | ||
| Widowed | 8(4.5) | 13(6.9) | ||
| Living arrangement | ||||
| Living alone | 22(12.4) | 22(11.7) | 0.037a | 0.847 |
| Living with others | 156(87.6) | 166(88.3) | ||
| Residential area | ||||
| Rural | 59(33.1) | 78(41.5) | 2.849a | 0.241 |
| Town | 31(17.4) | 31(16.5) | ||
| Urban | 88(49.4) | 79(42) | ||
| Primary caregiver | ||||
| Spouse | 117(65.7) | 106(56.4) | 7.631a | 0.106 |
| Parents | 2(1.1) | 11(5.9) | ||
| Children | 39(21.9) | 47(25.0) | ||
| Employees | 1(0.6) | 1(0.5) | ||
| Other | 19(10.7) | 23(12.2) | ||
| Educational background | ||||
| Primary school or below | 54(30.3) | 72(38.3) | 4.362a | 0.225 |
| Middle school | 57(32.0) | 60(31.9) | ||
| High school | 46(25.8) | 43(22.9) | ||
| University or above | 21(11.8) | 13(6.9) | ||
| Household monthly income(CNY) | ||||
| <2000 | 57(32.0) | 82(43.6) | 8.200a | 0.042* |
| 2000–4,999 | 85(47.8) | 84(44.7) | ||
| 5,000–9,999 | 35(19.7) | 22(11.7) | ||
| >10,000 | 1(0.6) | 0(0) | ||
| Number of stroke episodes | ||||
| First episode | 118(66.3) | 120(63.8) | 0.244a | 0.622 |
| Recurrence | 60(33.7) | 68(36.2) | ||
| Number of lesions | ||||
| Single lesion | 103(57.9) | 84(44.7) | 6.360a | 0.012* |
| Multiple lesions | 75(42.1) | 104(55.3) | ||
| Hypertension comorbidity | ||||
| No | 69(38.8) | 40(21.3) | 13.371a | <0.001 |
| Yes | 109(61.2) | 148(78.7) | ||
| Diabetes comorbidity | ||||
| No | 123(69.1) | 118(62.8) | 1.632a | 0.201 |
| Yes | 55(30.9) | 70(37.2) | ||
| Cardiovascular comorbidity | ||||
| No | 155(87.1) | 151(80.3) | 3.048a | 0.081 |
| Yes | 23(12.9) | 37(19.7) | ||
| Other chronic comorbidities | ||||
| No | 162(91) | 167(88.8) | 0.479a | 0.489 |
| Yes | 16(9.0) | 21(11.2) | ||
| Smoking | ||||
| Yes | 81(45.5) | 70(37.2) | 2.581a | 0.108 |
| No | 97(54.5) | 118(62.8) | ||
| Alcohol drinking | ||||
| Yes | 51(28.7) | 44(23.4) | 1.310a | 0.252 |
| No | 127(71.3) | 144(76.6) | ||
| ADL | ||||
| 100 | 26(14.6) | 19(10.1) | 10.106a | 0.018* |
| 61–99 | 130(73.0) | 124(66.0) | ||
| 41–60 | 16(9.0) | 26(13.8) | ||
| ≤40 | 6(3.4) | 19(10.1) | ||
General and clinical characteristics of sample [N = 366, n (%)].
CNY, Chinese yuan; a: χ2, b: F, *p < 0.05. Class 1, Low-FoP Adaptive Type; Class 2, High-FoP Sustained Type.
3.2 LPA results of patients’ FoP-Q-SF levels
As summarized in Table 2, AIC, BIC, and ABIC values decreased progressively with the addition of profiles. The 2-class model had an entropy of 0.919 (> 0.80), and both LMR (p < 0.001) and BLRT (p < 0.001) were significant. The average posterior probabilities for the two classes were both 0.98, indicating superior fit compared to the 1-class model. Thus, the 2-class model was selected as the optimal solution.
Table 2
| Profile | Class 1 | Class 2 | Class 3 | Class 4 | Class 5 |
|---|---|---|---|---|---|
| AIC | 14681.002 | 12984.083 | 12353.584 | 12028.705 | 11833.032 |
| BIC | 14774.665 | 13128.481 | 12548.715 | 12274.570 | 12129.632 |
| ABIC | 14698.523 | 13011.095 | 12390.085 | 12074.696 | 11888.514 |
| Entropy | NA | 0.919 | 0.917 | 0.907 | 0.910 |
| LMR (P) | NA | <0.001 | 0.152 | 0.051 | 0.085 |
| BLRT (P) | NA | <0.001 | <0.001 | <0.001 | <0.001 |
| Category probability | 1.0 | 48.6/51.4 | 30.9/49.7/19.4 | 15.8/15.6/32.0/36.6 | 35.8/15.8/18.6/18.9/10.9 |
Model Fit Indices for FoP Levels in Stroke Patients (N = 366).
AIC, Akaike Information Criterion; BIC, Bayesian Information Criterion; ABIC, Adjusted Bayesian Information Criterion; LMR, Lo–Mendell–Rubin; FoP, fear of progression; BLRT, Bootstrap Likelihood Ratio Test; NA, No Application.
The average posterior probabilities for C1 and C2 were 97.9 and 97.6%, respectively, confirming high classification accuracy. The mean scores of FoP-Q-SF items across subgroups are presented in Figure 1 and Table 3. Class 1 (C1, 48.6%) had overall lower item scores (1.91 ± 0.27) with a stable profile, labeled as “Low-FoP Adaptive Type.” Class 2 (C2, 51.4%) had significantly higher item scores (3.50 ± 0.53), labeled as “High-FoP Sustained Type.” Both subgroups scored highest on Item 1 (“I am afraid that my condition will worsen”), with C2 scoring 4.11 ± 0.81 and C1 scoring 2.37 ± 0.87.
Figure 1
Table 3
| FoP-Q-SF items | C1 Mean (SD) | C2 Mean (SD) |
|---|---|---|
| F1 Being afraid of disease progression | 2.37(0.87) | 4.11(0.81) |
| F2 Being nervous prior to doctor’s appointment or periodic examinations | 1.75(1.02) | 3.08(1.22) |
| F3 Being afraid of pain | 1.75(1.09) | 2.93(1.26) |
| F4 Being afraid of becoming less productive at work | 2.00(0.99) | 3.88(1.03) |
| F5 Having physical symptoms (e.g., rapid heartbeat, stomach ache) | 1.61(0.99) | 3.11(1.22) |
| F6 Being afraid by the possibility that the children could contract the disease | 1.48(1.05) | 2.61(1.32) |
| F7 Being afraid of relying on strangers for activities of daily living | 2.25(1.04) | 4.02(1.03) |
| F8 Being afraid of no longer being able to pursue hobbies | 2.10(0.94) | 3.88(0.91) |
| F9 Being afraid of severe medical treatments in the course of the illness | 1.88(0.99) | 3.53(1.14) |
| F10 Worrying that medication could damage the body | 1.71(1.04) | 2.96(1.23) |
| F11 Worrying what will become of family if something happens to me | 2.19(0.96) | 4.10(0.89) |
| F12 Being afraid of not being able to work anymore | 1.86(1.03) | 3.75(1.12) |
Comparison of FoP-Q-SF item scores across different FoP latent classes.
FoP-Q-SF, Fear of Progression Questionnaire-Short Form; SD, Standard Deviation; Class 1, Low-FoP Adaptive Type; Class 2, High-FoP Sustained Type.
3.3 Univariate analysis of factors associated with FoP latent classes
The two latent classes of FoP in stroke patients demonstrated statistically significant differences (p < 0.05) across the following variables: age, gender, monthly income, number of lesions, hypertension comorbidity, ADL scores, NIHSS scores, RRPSS scores, and perceived recurrence risk scores, avoidance, and resignation dimensions in MCMQ. The findings are presented in Tables 1, 4.
Table 4
| Variables | Class 1 n(%) | Class 2 n(%) | χ2 /F | p |
|---|---|---|---|---|
| NIHSS | ||||
| Mild stroke | 149(83.7) | 126(67.0) | 13.768a | <0.001 |
| Moderate stroke | 27(15.2) | 59(31.4) | ||
| Severe stroke | 2(1.1) | 3(1.6) | ||
| RRPSS | 49.42 ± 10.08 | 53.70 ± 10.35 | 2.474b | <0.001 |
| MCMQ | ||||
| Confrontation | 16.22 ± 4.50 | 16.89 ± 4.65 | 0.007b | 0.163 |
| Avoidance | 12.53 ± 2.30 | 13.14 ± 2.65 | 1.058b | 0.020* |
| Resignation | 7.93 ± 3.18 | 10.17 ± 3.62 | 4.373b | <0.001 |
Univariate analysis of FoP in stroke patients [N = 366, n (%)].
a: χ2, b: F, *p < 0.05. NIHSS, National Institutes of Health Stroke Scale; RRPSS, Recurrence Risk Perception Scale for Patients with Stroke; MCMQ, Medical Coping Modes Questionnaire.
3.4 Factors influencing the latent class membership of FoP in stroke patients
The R3STEP method was used to analyze the influencing factors of FoP subgroup membership (reference group: Low-FoP Adaptive Type [C1]). The results showed that age 18–59 years, hypertension comorbidity, higher RRPSS score, MCMQ-confrontation, and MCMQ-avoidance were significant influencing factors (all p < 0.05). Gender, number of lesions, NIHSS score, and ADL score were not statistically significant (all p > 0.05). Detailed results are shown in Table 5.
Table 5
| Variables | Class 2 | 95% CI | p | |
|---|---|---|---|---|
| B(SE) | OR | |||
| Gender (Female = 0) | ||||
| Male | 0.481(0.275) | 1.617 | 0.944–2.773 | 0.081 |
| Age (≥ 60 years = 0) | ||||
| 18–59 years | −0.742(0.338) | 0.476 | 0.245–0.924 | 0.028* |
| Household monthly income (< CNY 5000 = 0) | ||||
| ≥ CNY 5000 | 0.489(0.385) | 1.631 | 0.767–3.468 | 0.204 |
| Number of lesions (Multiple = 0) | ||||
| Single | 0.500(0.257) | 1.649 | 0.996–2.728 | 0.052 |
| Hypertension Comorbidity (No = 0) | ||||
| Yes | −0.911(0.270) | 0.402 | 0.237–0.683 | 0.001* |
| RRPSS | −0.030(0.013) | 0.971 | 0.946–0.995 | 0.022* |
| MCMQ | ||||
| Confrontation | −0.083(0.033) | 0.920 | 0.863–0.982 | 0.011* |
| Avoidance | −0.228(0.049) | 0.796 | 0.723–0.876 | <0.001 |
| Resignation | −0.076(0.049) | 0.927 | 0.842–1.020 | 0.119 |
Regression analysis of FoP in stroke patients.
OR, odds ratio, 95% CI, 95% confidence interval, *p < 0.05. Reference group, Low-FoP Adaptive Type (Class 1); Class 2, High-FoP Sustained Type.
3.5 Results of difference tests for outcome variables between the two groups of participants
For stroke patients with different latent FoP profiles, statistically significant differences were observed in RRPSS, NIHSS, MCMQ-avoidance, and MCMQ-resignation (p < 0.05). Specifically, stroke patients in the High-FoP Sustained Type (C2) not only exhibited stronger subjective recurrence concerns ( = 53.812, SE = 0.772) and more severe neurological impairment ( = 4.096, SE = 0.319), but also tended to adopt negative coping styles such as avoidance ( = 10.227, SE = 0.270) and resignation ( = 13.171, SE = 0.198), as shown in Table 6.
Table 6
| Variables | Class 1 | Class 2 | χ2 | p | ||
|---|---|---|---|---|---|---|
| SE | SE | |||||
| RRPSS | 49.319 | 0.770 | 53.812 | 0.772 | 16.204 | <0.001 |
| NIHSS | 2.781 | 0.260 | 4.096 | 0.319 | 9.737 | 0.002* |
| MCMQ | ||||||
| Confrontation | 16.210 | 0.344 | 16.894 | 0.347 | 1.857 | 0.171 |
| Avoidance | 7.882 | 0.243 | 10.227 | 0.270 | 39.744 | <0.001 |
| Resignation | 12.514 | 0.176 | 13.171 | 0.198 | 5.864 | 0.015* |
Analysis of differences in outcome variables among fop subgroups in stroke patients.
*p < 0.05. Class 1, Low-FoP Adaptive Type; Class 2, High-FoP Sustained Type.
4 Discussion
This study identified FoP heterogeneity via LPA using the FoP-Q-SF in stroke patients. We identified two distinct latent subgroups: “Low-FoP Adaptive Type” (C1: 48.6%) and “High-Fop Sustained Type” (C2, 51.4%). Furthermore, it further validated the correlates of FoP subgroups and between-class outcome differences by employing R3STEP for covariate analysis and BCH for outcome comparison. R3STEP and BCH analyzes confirmed that age 18–59 years, hypertension comorbidity, excessive recurrence risk perception, MCMQ-confrontation and MCMQ-avoidance were associated with high FoP. Additionally, high FoP patients had more severe neurological deficits (higher NIHSS score) and poorer adaptive coping abilities, highlighting the clinical significance of FoP stratification for stroke rehabilitation. These findings help identify high-risk populations early and develop personalized rehabilitation strategies to reduce FoP and improve outcomes.
In our study, the mean score of FoP was 32.67 ± 11.84, with 46.4% of patients scoring ≥ 34 points. This result is lower than those of studies on myocardial infarction and breast cancer patients (Wang X. et al., 2024; Zhuang et al., 2024), but significantly higher than colon cancer patients (Hu et al., 2024). Notably, the C2 subgroup accounted for 51.4% of the sample, indicating an overall elevated level of FoP among stroke patients, consistent with the findings of a meta-analysis by Yang et al. (2025). Participants in both subgroups scored relatively high on Item 1 (“I am afraid that my condition will worsen”). Although the C2 group scored significantly higher than the C1 group, this finding revealed a fundamental psychological vulnerability common to stroke patients. This divergence may stem from several factors, such as the following.
First, although recurrence rates in stroke patients have declined from 18 to 12% (Wang Y. et al., 2024), lingering uncertainty perpetuates disease progression anxiety. Moreover, persistent functional deficits, such as motor impairment and aphasia, act as tangible disease reminders, fueling immediate fear responses. Second, stroke rehabilitation entails prolonged, complex therapeutic regimens that potentially exacerbate adverse psychological outcomes (Lavados et al., 2021). Patients with stroke show relatively low psychological resilience (Wang Y. et al., 2024), and 31% with psychological stress (Almhdawi et al., 2021), which severely impedes rehabilitation and may further amplify FoP. This reminds healthcare providers and caregivers to focus not only on rehabilitation outcomes but also on active monitoring of psychological shifts and timely mental health interventions.
4.1 Pay attention to elderly populations
Our study confirmed that patients aged 18–59 years had a significantly lower risk of belonging to the High-FoP Sustained Type (C2) compared with those ≥ 60 years, which is consistent with the study by Liu Y. et al. (2025) and others on patients with hematologic malignancy. Elderly patients (≥ 60 years) generally require a higher level of care, often face greater physical function decline, longer rehabilitation cycles, and relatively modest rehabilitation expectations. Their fear stems not only from the pain of the illness itself but is also closely tied to concerns about their ability to fulfill family roles and responsibilities (Li et al., 2025). As a result, they are more prone to heightened concern over “disability and dependence resulting from disease progression.” In contrast, younger patients (18–59 years) typically have stronger rehabilitation potential and higher confidence in prognosis, even when shouldering multiple social roles (e.g., family breadwinners; Liu R. et al., 2025). This suggests that clinical practice should establish an age-stratified intervention model, prioritizing psychological support for elderly stroke patients to mitigate their elevated risk of sustained high FoP.
4.2 The impact of disease-related factors on FoP
An interesting result was found, which revealed that stroke patients with hypertension comorbidity were less likely to be classified as C2 than those without hypertension, which was inconsistent with the findings of another study (Song et al., 2021). This counterintuitive finding may be explained by the fact that patients with hypertension have long engaged in chronic disease management (e.g., regular medication, blood pressure monitoring), accumulating experience in symptom control and disease adaptation. Such experience enhances their tolerance for illness fluctuations and reduces excessive fear of stroke progression. This insight suggests that clinical teams can leverage hypertension management frameworks to integrate “disease adaptation training” into stroke rehabilitation, helping patients build confidence in illness control.
Our study showed a negative association between RRPSS scores and C2 membership, indicating that higher perceived recurrence risk is associated with a lower likelihood of sustained high FoP. Patients with higher perceived recurrence risk may proactively adopt health behaviors (e.g., adhering to medication, participating in rehabilitation) to reduce actual recurrence probability, and this sense of “controllability” mitigates excessive fear (Lei et al., 2025). Clinically, this implies that interventions should not merely aim to “reduce risk perception” but rather guide patients to transform risk awareness into constructive behaviors—for example, through personalized recurrence risk communication and coping skill training (Lin et al., 2021b).
Coping styles emerged as key correlates of FoP subgroups. R3STEP analysis showed that higher MCMQ confrontation scores and higher avoidance scores both reduced C2 membership risk, while BCH results confirmed that C2 patients had significantly higher resignation scores and avoidance scores. These findings highlight the dual nature of coping styles: (1) Confrontation, as an active coping strategy, reduces FoP by encouraging patients to address disease-related issues (e.g., consulting clinicians, participating in rehabilitation), which is consistent with another study (Wang et al., 2025). (2) Avoidance exhibits a complex “protective-burden” duality: it may temporarily buffer stress and alleviate acute anxiety in the short term (Chen et al., 2025); yet, persistent reliance on it can lead to the neglect of rehabilitation and an exacerbation of functional decline, ultimately trapping patients in a maladaptive cycle of “high fear - excessive avoidance - poor recovery.” (Thewes et al., 2016) Stroke patients may experience psychological distress due to various adverse outcomes, such as activity limitations, poor rehabilitation outcomes, social isolation, and poor functional recovery, which can lead them to adopt negative coping strategies, and inadvertently increases FoP (Weerasekara et al., 2024). Healthcare professionals should provide structured health education to guide patients in developing accurate disease understanding, dynamically monitor psychological changes, and empower patients to adopt adaptive coping strategies (e.g., transforming excessive avoidance into temporary stress management, strengthening confrontation skills) to mitigate FoP and enhance rehabilitation outcomes.
4.3 Limitations
This study has several limitations. First, the non-representative sampling method constrains the generalizability of the results. Future research should expand recruitment through multi-center studies across diverse regions to comprehensively characterize FoP heterogeneity among stroke patients. Second, the cross-sectional design cannot establish causal relationships or track long-term FoP trajectories. Longitudinal studies are needed to explore how FoP evolves during rehabilitation and its long-term impact on outcomes. Third, the MCMQ subscales for confrontation (Cronbach’s α = 0.64) and resignation (α = 0.67) had relatively low reliability, which may have led to attenuation bias in the results; future studies could use more reliable coping assessment tools or supplement item-total correlations for validation. Fourth, the examined determinants were limited to individual-level factors (sociodemographic, clinical, psychological). Future research should incorporate contextual factors (e.g., family support, healthcare system accessibility, social stigma) to develop a more holistic understanding of FoP.
4.4 Implications
To address diverse patient needs, clinical interventions should be customized according to the patient profile. Tailored health guidance and rehabilitation strategies are essential for different FoP subgroups. For patients with low FoP, key approaches include health education, psychological support, and mindfulness-based interventions. In contrast, for patients with high FoP, intensive personalized therapies, such as cognitive behavioral therapy (CBT) may be needed. Furthermore, integrating robust family and social support systems into stroke rehabilitation programs is critical for improving outcomes. This comprehensive approach effectively reduces FoP and enhances recovery outcomes.
5 Conclusion
This study identified two distinct latent profiles of FoP (Low-FoP Adaptive Type, High-FoP Sustained Type) among 366 stroke patients using LPA. R3STEP and BCH analyzes confirmed that younger age (18–59 years), hypertension comorbidity, excessive recurrence risk perception, MCMQ-confrontation, and MCMQ-avoidance were associated with high FoP. High FoP patients also had more severe neurological deficits and poorer adaptive coping abilities. These findings highlight significant FoP heterogeneity among stroke patients, emphasizing the need for early identification of high-risk individuals and targeted interventions. The results support the development of precision rehabilitation strategies to reduce FoP, enhance functional outcomes, and improve quality of life. Future research should use longitudinal and multi-center designs, incorporate contextual factors, and validate more reliable assessment tools to further explore FoP in stroke patients.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving humans were approved by Lanzhou University Second Hospital, Lanzhou, China. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.
Author contributions
YL: Data curation, Writing – original draft. XL: Writing – original draft, Data curation. TZ: Writing – review & editing, Investigation. BW: Investigation, Writing – review & editing. LH: Methodology, Writing – review & editing. YX: Methodology, Writing – review & editing. JX: Writing – review & editing, Formal analysis. MZ: Writing – review & editing, Formal analysis. YW: Investigation, Writing – review & editing. XD: Funding acquisition, Writing – review & editing, Project administration. WL: Writing – review & editing, Investigation, Project administration. XW: Project administration, Writing – review & editing, Funding acquisition.
Funding
The author(s) declared that financial support was received for this work and/or its publication. The authors are grateful for the support from the following grants: Cuiying Scientific Training Program for Undergraduates of The Second Hospital & Clinical Medical School, Lanzhou University (No. CYXZ2023-32); The 5th Batch of Gansu Provincial Science and Technology Program (No. 24JRRA925) and Gansu Provincial Health Industry Scientific Research Project (Nos. GSWSHL2024-28 and GSWSHL2024-34).
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that Generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AlmhdawiK. A.AlazraiA.KanaanS.ShyyabA. A.OteirA. O.MansourZ. M.et al. (2021). Post-stroke depression, anxiety, and stress symptoms and their associated factors: a cross-sectional study. Neuropsychol. Rehabil.31, 1091–1104. doi: 10.1080/09602011.2020.1760893,
2
ChenL.LiH.GouX.DongH.YangS.DongF.et al. (2025). Coping as a mediator of the relationship between kinesiophobia and illness perception in atrial fibrillation patients: a cross-sectional mediation analysis. J. Adv. Nurs.81, 848–859. doi: 10.1111/jan.16262,
3
ChoiY. O.LeeJ. (2017). Impact of stroke knowledge, fear of recurrence on health behavior in patients with ischemic stroke. Korean J. Adult Nurs.29, 302–312. doi: 10.7475/kjan.2017.29.3.302,
4
FeiginV. L.StarkB. A.JohnsonC. O.RothG. A.BisignanoC.AbadyG. G.et al. (2021). Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol.20, 795–820. doi: 10.1016/S1474-4422(21)00252-0
5
FergusonS. L.MooreG. E.HullD. M. (2020). Finding latent groups in observed data: a primer on latent profile analysis in Mplus for applied researchers. Int. J. Behav. Dev.44, 458–468. doi: 10.1177/0165025419881721
6
FerroJ. M.SantosA. C. (2020). Emotions after stroke: a narrative update. Int. J. Stroke15, 256–267. doi: 10.1177/1747493019879662,
7
HuC.WengY.WangQ.YuW.ShanS.NiuN.et al. (2024). Fear of progression among colorectal cancer patients: a latent profile analysis. Support Care Cancer32:469. doi: 10.1007/s00520-024-08660-7,
8
KumralE.GüllüoğluH.AlakbarovaN.KaramanB.DeveciE. E.BayramovA.et al. (2015). Association of leukoaraiosis with stroke recurrence within 5 years after initial stroke. J. Stroke Cerebrovasc. Dis.24, 573–582. doi: 10.1016/j.jstrokecerebrovasdis.2014.10.002
9
LavadosP. M.HoffmeisterL.MoragaA. M.VejarA.VidalC.GajardoC.et al. (2021). Incidence, risk factors, prognosis, and health-related quality of life after stroke in a low-resource community in Chile (ÑANDU): a prospective population-based study. Lancet Glob. Health9, e340–e351. doi: 10.1016/S2214-109X(20)30470-8,
10
LebelS.TomeiC.FeldstainA.BeattieS.McCallumM. (2013). Does fear of cancer recurrence predict cancer survivors' health care use?Support Care Cancer21, 901–906. doi: 10.1007/s00520-012-1685-3,
11
LeiR.ZhangM.GuiG.YangD.HeL. (2025). How perceived risk of recurrence strengthens health management awareness in stroke patients: the chain mediating role of risk fear and health literacy. Front. Public Health13:1524492. doi: 10.3389/fpubh.2025.1524492,
12
LiJ.HeY.XieF.KangZ.MeiJ.MeiB. (2025). Fear of progression profiles and their association with quality of life and depression in ischemic stroke survivors: a latent profile analysis. BMC Psychiatry25:780. doi: 10.1186/s12888-025-07242-z,
13
LinB.ZhangZ.GuoY.WangW.KongP.LiuF.et al. (2021a). Development and reliability of the perceived risk of recurrence assessment scale for stroke patients. Chin. J. Nurs.56, 1666–1671. doi: 10.3761/j.issn.0254-1769.2021.11.011
14
LinB.ZhangZ.GuoY.WangW.MeiY.WangS.et al. (2021b). Perceptions of recurrence risk and behavioural changes among first-ever and recurrent stroke survivors: a qualitative analysis. Health Expect.24, 1962–1970. doi: 10.1111/hex.13335,
15
LiuR.LiuJ.SongJ.PengY.JinG.LiJ. (2025). Mediating effect of social support in the relationship of symptom burden and fear of disease progression in stroke patients. J. Stroke Cerebrovasc. Dis.34:108215. doi: 10.1016/j.jstrokecerebrovasdis.2024.108215,
16
LiuL.XuM.MarshallI. J.WolfeC. D.WangY.O’ConnellM. D. (2023). Prevalence and natural history of depression after stroke: a systematic review and meta-analysis of observational studies. PLoS Med.20:e1004200. doi: 10.1371/journal.pmed.1004200
17
LiuY.ZhangQ.ZhaoJ.ZhangT.TianF.WangZ.et al. (2025). Latent profile analysis of fear of progression in Chinese hematologic malignancy survivors. Sci. Rep.15:15265. doi: 10.1038/s41598-025-00415-6,
18
MaQ.LiR.WangL.YinP.WangY.YanC.et al. (2021). Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the global burden of disease study 2019. Lancet Public Health6, e897–e906. doi: 10.1016/s2468-2667(21)00228-0,
19
MahendranR.LiuJ.KuparasundramS.GrivaK. (2020). Validation of the English and simplified mandarin versions of the fear of progression questionnaire–short form in Chinese cancer survivors. BMC Psychol.8, 1–7. doi: 10.1186/s40359-020-0374-0
20
MarshH. W.LüdtkeO.TrautweinU.MorinA. J. (2009). Classical latent profile analysis of academic self-concept dimensions: synergy of person-and variable-centered approaches to theoretical models of self-concept. Struct. Equ. Model.16, 191–225. doi: 10.1080/10705510902751010
21
PuY. H.ZouX. Y.WangY. L.PanY. S.XiangX. L.SooA. X.et al. (2018). Difference of one year death and stroke recurrence in ischemic stroke patients with anterior and posterior circulation intracranial atherosclerosis. Zhonghua Yi Xue Za Zhi98, 502–507. doi: 10.3760/cma.j.issn.0376-2491.2018.07.004,
22
RebA. M.BornemanT.EconomouD.CanginM. A.PatelS. K.SharpeL. (2020). Fear of cancer progression: findings from case studies and a nurse-led intervention. Clin. J. Oncol. Nurs.24, 400–408. doi: 10.1188/20.CJON.400-408,
23
RundeD. (2020). Calculated decisions: NIH stroke scale/score (NIHSS). Emerg. Med. Pract.22, CD6–CD7.
24
SchapiraL.ZhengY.GelberS. I.PoorvuP.RuddyK. J.TamimiR. M.et al. (2022). Trajectories of fear of cancer recurrence in young breast cancer survivors. Cancer128, 335–343. doi: 10.1002/cncr.33921
25
ShenX. H.JiangQ. J. (2000). Report on application of Chinese version of MCMQ in 701 patients. Chin. J. Behav. Med. Sci.9, 18–20. http://www.cnki.net
26
SongJ.MurugiahK.HuS.GaoY.LiX.KrumholzH. M.et al. (2021). Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China. Heart107, 313–318. doi: 10.1136/heartjnl-2020-317165
27
StinearC. M.LangC. E.ZeilerS.ByblowW. D. (2020). Advances and challenges in stroke rehabilitation. Lancet Neurol.19, 348–360. doi: 10.1016/S1474-4422(19)30415-6,
28
TeinJ. Y.CoxeS.ChamH. (2013). Statistical power to detect the correct number of classes in latent profile analysis. Struct. Equ. Model.20, 640–657. doi: 10.1080/10705511.2013.824781,
29
ThewesB.LebelS.Seguin LeclairC.ButowP. (2016). A qualitative exploration of fear of cancer recurrence (FCR) amongst Australian and Canadian breast cancer survivors. Support Care Cancer24, 2269–2276. doi: 10.1007/s00520-015-3025-x,
30
WangQ.GuJ.LinZ.LiS.ZhouM.YangJ.et al. (2025). Social alienation in patients with inflammatory bowel diseases: a latent profile analysis. Int. J. Nurs. Sci.12, 335–343. doi: 10.1016/j.ijnss.2025.06.007,
31
WangX.JiangN.ChenS.TuerdiS.YangJ.YanR.et al. (2024). Fear of progression in patients with acute myocardial infarction: a cross-sectional study. BMC Nurs.23:866. doi: 10.1186/s12912-024-02552-1,
32
WangY.XieH.SunH.RenL.JiangH.ChenM.et al. (2024). Influencing factors of psychological resilience in stroke patients: a systematic review and Meta-analysis. Arch. Clin. Neuropsychol.39, 644–654. doi: 10.1093/arclin/acad107,
33
WeerasekaraP.WarshawithanaC.WeerasingheN.MashoodI. (2024). Prevalence and associated factors of psychological distress of patients with stroke attending a neurology clinic—an analytical cross-sectional study. Int. J. Med. Students12, 415–421. doi: 10.5195/ijms.2024.2454
34
WuQ.YeZ.LiL.LiuP. (2015). Reliability and validity of Chinese version of fear of progression questionnaire-short form for cancerpatients. Chin. J. Nurs.50, 1515–1519. doi: 10.3761/j.issn.0254-1769.2015.12.021
35
YangZ.ChenC.WangM.YangY.XuL. (2025). Prevalence and factors influencing fear of disease progression in stroke patients: a systematic review and meta-analysis with a focus on China. BMJ Open15:e091605. doi: 10.1136/bmjopen-2024-091605,
36
ZhangL.ShiY.DengJ.YiD.ChenJ. A. (2023). The effect of health literacy, self-efficacy, social support and fear of disease progression on the health-related quality of life of patients with cancer in China: a structural equation model. Health Qual. Life Outcomes21:75. doi: 10.1186/s12955-023-02159-1,
37
ZhuangJ.WangY.WangS.HuR.WuY.ChenL. (2024). Fear of disease progression, self-management efficacy, and family functioning in patients with breast cancer: a cross-sectional relationship study. Front. Psychol.15:1400695. doi: 10.3389/fpsyg.2024.1400695
Summary
Keywords
cerebrovascular accidents, fear of progression, latent profile analysis, risk factors, risk perception, stroke patients
Citation
Liu Y, Li X, Zhao T, Wan B, Han L, Xi Y, Xiong J, Zhang M, Wang Y, Dou X, Li W and Wang X (2026) Fear of progression and association factors in stroke patients: a latent profile analysis. Front. Psychol. 17:1741344. doi: 10.3389/fpsyg.2026.1741344
Received
07 November 2025
Revised
02 February 2026
Accepted
17 February 2026
Published
03 March 2026
Volume
17 - 2026
Edited by
Rizaldy Taslim Pinzon, Duta Wacana Christian University, Indonesia
Reviewed by
Cansu Aykaç, Dokuz Eylul University, Türkiye
Pumudu Weerasekara, Ministry of Health, Nutrition and Indigenous Medicine, Sri Lanka
Updates
Copyright
© 2026 Liu, Li, Zhao, Wan, Han, Xi, Xiong, Zhang, Wang, Dou, Li and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xinglei Wang, 1106087304@qq.com; Weiping Li, 2570436525@qq.com
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.